+23.0%
GSK vs BBAI
-42.1%
+65.1%
-19.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BBAI | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.0% | -0.4% | -0.7% | -1.1% |
| 7D | -5.4% | -5.4% | 0.0% | -5.5% |
| 30D | -4.6% | -15.3% | +10.7% | -4.8% |
| 3M | -5.1% | -29.9% | +24.7% | -5.4% |
| 6M | -11.4% | -30.7% | +19.3% | -11.9% |
| YTD | +0.7% | -47.8% | +48.5% | +0.1% |
| 1Y | +23.0% | -40.4% | +63.4% | +22.9% |
| All | +23.0% | -42.1% | +65.1% | +22.9% |
Cumulative growth
Daily Returns
Daily percentage return beside BBAI.
Daily Out/Under-Performance
Portfolio return minus BBAI return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBAI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BBAI wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling